2010Chinese Journal of Clinical PharmacyRequires access

Effects of Tanshinone II_A on SDF-1/CXCR4 from peripheral blood in patients with type 2 diabetes mellitus

QI Chuan-ping

Open publisher page 0 citations

Abstract

AIM To study effect of TanshinoneⅡA(TanⅡA) on stromal cell-derived factor-1(SDF-1) and it's receptors CXCR4 in patients with type 2 diabetes mellitus(T2DM).METHODS Sixty-two patients with T2DM were randomly divided into treatment and control groups.TanⅡA 40 mg·d-1 was given to patients in treatment group for 2 weeks.The level of plasma SDF-1,the positive rate of CXCR4 on endothelial progenitor cells(EPCs)and the number of EPCs were determined pre-and post-treatment.RESULTS All parameters had no significant differences between 2 groups before observation(P0.05).Increasing SDF-1,EPCs and CXCR4 had significant difference in the treatment group pre-and post-treatment(P0.05 or P0.01).The parameters had no significant differences between before and after observation in the control group(P0.05).There was a significant positive correlation between EPCs and SDF-1(r=0.223,P0.05).CONCLUSION TanⅡA can improve vascular endothelial function in T2DM,which may be due to elevating the level of plasma SDF-1 and increasing the expression of CXCR4 on EPCs,and inducing EPCs mobilization from bone marrow to peripheral blood.

About this research paper

What this paper is about

AIM To study effect of TanshinoneⅡA(TanⅡA) on stromal cell-derived factor-1(SDF-1) and it's receptors CXCR4 in patients with type 2 diabetes mellitus(T2DM).METHODS Sixty-two patients with T2DM were randomly divided into treatment and control groups.TanⅡA 40 mg·d-1 was given to patients in treatment group for 2 weeks.The level of plasma SDF-1,the positive rate of CXCR4 on endothelial progenitor cells(EPCs)and the number of EPCs were determined pre-and post-treatment.RESULTS All parameters had no significant differences between 2 groups before observation(P0.05).Increasing SDF-1,EPCs and CXCR4 had significant difference in the treatment group pre-and post-treatment(P0.05 or P0.01).The parameters had no significant differences between before and after observation in the control group(P0.05).There was a significant positive correlation between EPCs and SDF-1(r=0.223,P0.05).CONCLUSION TanⅡA can improve vascular endothelial function in T2DM,which may be due to elevating the level of plasma SDF-1 and increasing the expression of CXCR4 on EPCs,and inducing EPCs mobilization from bone marrow to peripheral blood.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM To study effect of TanshinoneⅡA(TanⅡA) on stromal cell-derived factor-1(SDF-1) and it's receptors CXCR4 in patients with type 2 diabetes mellitus(T2DM).METHODS Sixty-two patients with T2DM were randomly divided into treatment and control groups.TanⅡA 40 mg·d-1 was given to patients in treatment group for 2 weeks.The level of plasma SDF-1,the positive rate of CXCR4 on endothelial progenitor cells(EPCs)and the number of EPCs were determined pre-and post-treatment.RESULTS All parameters had no significant differences between 2 groups before observation(P0.05).Increasing SDF-1,EPCs and CXCR4 had significant difference in the treatment group pre-and post-treatment(P0.05 or P0.01).The parameters had no significant differences between before and after observation in the control group(P0.05).There was a significant positive correlation between EPCs and SDF-1(r=0.223,P0.05).CONCLUSION TanⅡA can improve vascular endothelial function in T2DM,which may be due to elevating the level of plasma SDF-1 and increasing the expression of CXCR4 on EPCs,and inducing EPCs mobilization from bone marrow to peripheral blood.

Key concepts: Stromal cell-derived factor 1, CXCR4, Progenitor cell, Stromal cell, Endothelial progenitor cell, Medicine, Type 2 Diabetes Mellitus, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Tanshinone II_A on SDF-1/CXCR4 from peripheral blood in patients with type 2 diabetes mellitus — Research Paper | ScholarLens